Endocannabinoids and related lipids linked to social exclusion in individuals with chronic non-medical prescription opioid use
Rattachement africain : ch, ca. Niveau de preuve : code pays fourni par la source.
Le résumé fourni par la source
Opioid-related overdose deaths are still on the rise in North America, emphasizing the need to better understand the underlying neurobiological mechanisms regarding the development of opioid use disorder (OUD). Recent evidence from preclinical and clinical studies indicate that the endocannabinoid system (ECS) may play a crucial role in stress and reward, both involved in the development and maintenance of substance use disorders. Animal models demonstrate a specific crosstalk between the ECS and the endogenous opioid system. However, translational studies in humans are scarce. Here, we investigated basal plasma levels of the endocannabinoids anandamide (AEA) and 2-arachidonoyglycerol (2-AG), and eight endocannabinoid-related lipids, including oleoylethanolamide (OEA) and palmitoylethanolamide (PEA), as well as whole blood fatty acid amide hydrolase (FAAH) activity in chronic non-medical prescription opioid users (NMPOU; n = 21) compared to opioid-naïve healthy controls (n = 29) considering age, sex, and cannabis use as potential confounders. Additionally, the association of endocannabinoids and related lipids with the participants' response to experimentally induced social exclusion was examined. We found significantly elevated basal AEA, OEA, and PEA levels in NMPOU compared to controls, but no differences in FAAH activity, 2-AG, or other endocannabinoid-related lipids. Within NMPOU, higher AEA levels were associated with lower perception of social exclusion. Robust positive correlations within N-acylethanolamines (i.e., AEA, OEA, and PEA) indicate strong metabolic associations. Together with our recent findings of elevated basal 2-AG levels in dependent cocaine users, present results indicate substance-specific alterations of the ECS that may have implications in the search for novel therapeutic interventions for these populations.
Ce résumé expose les affirmations des auteurs. BNTIC ne l’interprète pas comme une validation indépendante des résultats.
Le contrôle bibliographique ouvert
DOI retrouvé dans Crossref DOI retrouvé ; titre concordant.
- Titre Crossref
- Endocannabinoids and related lipids linked to social exclusion in individuals with chronic non-medical prescription opioid use
- Date Crossref
- 21/05/2024
- Éditeur
- Springer Science and Business Media LLC
- Type
- journal-article
Ce recoupement confirme des métadonnées liées au DOI. Il ne confirme ni la méthode ni les conclusions de l’étude, et il ne compte pas comme une seconde source scientifique indépendante.
Où se fait cette recherche
-
University of Zurich Neuroscience Center Zurich pays non établi dans la noticeUniversité ou école supérieure
-
University Hospital Zurich pays non établi dans la noticeÉtablissement de santé
-
University of Bern Institute of Biochemistry and Molecular Medicine pays non établi dans la noticeUniversité ou école supérieure
-
University of Calgary Hotchkiss Brain Institute pays non établi dans la noticeUniversité ou école supérieure
-
Mathison Centre for Mental Health Research and Education pays non établi dans la noticeStructure de recherche
-
University Hospital of Psychiatry Zurich Experimental and Clinical Pharmacopsychology pays non établi dans la noticeUniversité ou école supérieure
Neuroscience Center Zurich — University of Zurich, University Hospital Zurich et Institute of Biochemistry and Molecular Medicine — University of Bern, avec 3 autres affiliations.
Une affiliation ne permet pas de déduire la nationalité d’un auteur.